Establishing the Median Infectious Dose and Characterizing the Clinical Manifestations of Mouse, Rat, Cow, and Human

Gerardo Mendoza1, Christopher Cheleuitte-Nieves2, Kvin Lertpiriyapong3

  • 1Tri-Institutional Training Program in Laboratory Animal Medicine and Science, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, and The Rockefeller University, New York, New York; gm103746@gmail.

PubMed

Insights

Corynebacterium bovis isolates vary in infectivity and disease severity across different immunodeficient mouse models. Mouse-derived isolates were more infectious than bovine or rat isolates, impacting research outcomes.

Area of Science:

  • Microbiology
  • Immunology
  • Animal Models

Background:

  • Corynebacterium bovis (Cb) causes hyperkeratotic dermatitis in immunocompromised mice, potentially confounding research.
  • Limited knowledge exists regarding the infectivity and disease variations among different Cb isolates from various species.

Purpose of the Study:

  • To determine the infectious dose 50 (ID50) and clinical disease severity of Cb isolates from mice, rats, cows, and humans.
  • To compare the infectivity and disease progression of Cb isolates in athymic nude mice and two furred immunocompromised mouse strains (NSG and NSG-S).

Main Methods:

  • Determined ID50 and clinical signs in athymic nude mice inoculated with Cb isolates from diverse sources.
  • Assessed ID50 and disease parameters in NSG and NSG-S mice using selected mouse Cb isolates.
  • Quantified bacterial colonization via skin swabs and scored clinical signs daily for 14 days.

Main Results:

  • Mouse Cb isolates exhibited lower ID50 values (58-1000 bacteria) compared to bovine (6460-7498 bacteria) and rat (10,000 bacteria) isolates.
  • Human Cb isolates did not colonize or cause disease in mice.
  • Furred immunocompromised mice required significantly higher inoculum for colonization and developed disease later than athymic nude mice.

Conclusions:

  • Significant variability exists in Cb infectivity (ID50), disease course, and clinical signs based on the isolate source.
  • Different immunodeficient mouse strains exhibit distinct responses to Cb infection, influencing disease onset and severity.
  • Understanding isolate-specific and host-specific differences is crucial for managing Cb infections in research settings.